METHOD OF SCREENING PHARMACEUTICALS FOR DRUG INTERACTIONS AND NEPHROTOXICITY

• 1. 白花前胡甲素在制备缓解抗肿瘤药物顺铂所致肾毒性的药物中的应用 [P] . 中国专利： CN109260194B . 2021.03.02
• 2. 新型药物体外温孵、代谢物寻找、药物-药物相互作用预测快速筛选与分析整合策略 [P] . 中国专利： CN106770693A . 2017-05-31
• 3. A method to identify interactions between two Drugs and the provision of screening Libraries to determine the interaction of a drug test with a member of a library in a drug test [P] . AR037141A1 . 2004-10-27

  机译： 一种识别两种药物之间相互作用的方法，并提供筛选库来确定药物测试与药物测试中库成员的相互作用

• 4. Screening system for identifying drug-drug interactions and methods of use thereof [P] . 美国专利： US2008194421A1 . 2008-08-14

  机译： 识别药物相互作用的筛选系统及其使用方法

• 5. A SCREENING SYSTEM FOR IDENTIFYING DRUG-DRUG INTERACTIONS AND METHODS OF USE THEREOF [P] . 欧洲知识产权局专利： EP1432986A4 . 2007-02-21

  机译： 用于识别药物相互作用的筛选系统及其使用方法

• 1. Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction [J] . Weina Ma, Liu Yang, Langchong He 药物分析学报（英文） . 2018,第003期
• 2. Selective micellar electrokinetic chromatographic method for simultaneous determination of some pharmaceutical binary mixtures containing non-steroidal anti-inflammatory drugs [J] . Michael E.El-Kommos, Niveen A.Mohamed, Ahmed F.Abdel Hakiem 药物分析学报（英文） . 2013,第001期
• 3. Chemical Modifier Screenings as Methods for Identifying Pathway-TargetingCompounds and for Predicting Drug-Drug Interactions [J] . Naoyuki Nishiya Organic Chemistry: Current Research . 2014,第2期
• 4. Noise Reduction Method for Molecular Interaction Energy:Application to in Silico Drug Screening and in Silico Target Protein Screening [J] . Yoshifumi Fukunishi, Satoru Kubota, Haruki Nakamura Journal of chemical information and modeling . 2006,第5期
• 5. Extended liquid chromatography high resolution mass spectrometry screening method for veterinary drug, pesticide and human pharmaceutical residues in aquaculture fish [J] . Turnipseed Sherri B., Storey Joseph M., Wu I-Lin, Food additives & contaminants . 2019,第10期
• 6. Establishment of a Method to Measure the Interaction Between Nedd4 and UbCH5c for Drug Screening [C] . Kunyuan Kou, Jianli Dang, Baoxia Zhang, International conference on applied biotechnology . 2015
• 7. Ambient ionization mass spectrometry for the forensic screening of pharmaceuticals and the determination of potential drug candidates. [D] . Nyadong, Leonard. 2009
• 8. Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method [O] . Roelof WF van Leeuwen, Eleonora L Swart, Frits A Boom, 2010
• 9. Chemical Modifier Screenings as Methods for Identifying Pathway-Targeting Compounds and for Predicting Drug-Drug Interactions [O] . Naoyuki Nishiya 2014

• 1. Stability Indicating RP-HPLC Method for the Determination of Dronedarone Hydrochloride and Its Potential Process-Related Impurities in Bulk Drug and Pharmaceutical Dosage Form [J] . Shashikant B. Landge ,Sanjay A. Jadhav ,Kapil P. Nimbalkara . 美国分析化学（英文） . 2013,第6期
• 2. An Ultra-sensitive LC Method for the Simultaneous Determination of Paracetamol, Carbamazepine, Losartan and Ciprofloxacin in Bulk Drug, Pharmaceutical Formulation and Human Serum by Programming the Detector [J] . Najma Sultana ,Muhammad Saeed Arayne ,Saeeda Nadir Ali . 美国分析化学（英文） . 2013,第1期
• 3. A Stability Indicating HPLC Method for Dronedarone in Bulk Drugs and Pharmaceutical Dosage Forms [J] . Naresh Tondepu ,Shakil S. Sait ,K.V. Surendranath . 美国分析化学（英文） . 2012,第8期
• 4. 药物转运体OATPs/Oatps在心血管药物的药动学及药物相互作用中的角色 [C] . Wen Jin Hua ,温金华 ,Wei Xiao Hua . 2013年中国临床药学学术年会暨第九届中国临床药师论坛 . 2013
• 5. 基于HK-2细胞评价药物肾毒性体外方法的建立 [A] . 王磊 . 2013